Key statistics
As of last trade Mirum Pharmaceuticals Inc (08D:FRA) traded at 35.00, -14.22% below its 52-week high of 40.80, set on Jul 29, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 34.60 |
---|---|
High | 35.00 |
Low | 34.40 |
Bid | 35.00 |
Offer | 36.00 |
Previous close | 35.80 |
Average volume | 0.00 |
---|---|
Shares outstanding | 47.71m |
Free float | 46.53m |
P/E (TTM) | -- |
Market cap | 1.87bn USD |
EPS (TTM) | -2.40 USD |
Data delayed at least 15 minutes, as of Oct 07 2024 14:29 BST.
More ▼
Press releases
- Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Mirum Pharmaceuticals to Participate in Upcoming Investor Conferences
- Mirum Pharmaceuticals Reports Second Quarter 2024 Financial Results and Provides Business Update
- Mirum Pharmaceuticals to Announce Second Quarter 2024 Financial Results and Host Conference Call on August 7, 2024
- Mirum’s LIVMARLI Now Approved for PFIC in Patients 12 Months and Older
More ▼